China approves AI software to assess symptoms of Parkinson's disease

Chinese startup NERVTEX's MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Artificial ...

February 3, 2023 | Friday | News
China-based startup CARsgen partners with Roche for gastric cancer treatment

CARsgen Therapeutics Holdings, a biopharmaceutical startup based in the US and China, has announced collaboration agreem...

February 2, 2023 | Thursday | News
Daewoong inks $336 M deal with CS Pharma for Idiopathic Pulmonary Fibrosis treatment in China

South Korea's Daewoong Pharmaceutical has secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based m...

February 1, 2023 | Wednesday | News
Duoning sets up global HQ and R&D centre at Fengxian Biotechnology Park in China

Shanghai Duoning Biotechnology Co. has signed an agreement on the Transfer of the Right to Use State-owned Construc...

January 31, 2023 | Tuesday | News
Hong Kong-based startup PanopticAI secures fundraising to digitise remote healthcare

PanopticAI, Hong Kong's leading health and wellness monitoring startup, has announced a deal closing on a seed...

January 30, 2023 | Monday | News
GenScript ProBio completes nearly $220 M Series C Round of financing in China

GenScript ProBio, a subsidiary of GenScript Biotech Corporation, has announced its Series C round of financing of n...

January 27, 2023 | Friday | News
China-based startup ReLive Biotechnologies strengthens presence in regenerative therapy market

ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed bi...

January 26, 2023 | Thursday | News
Hong Kong Science and Technology Parks Corp inks strategic collaboration with Roche

Hong Kong Science and Technology Parks (HKSTP) Corporation has announced a strategic collaboration with Roche, one of th...

January 19, 2023 | Thursday | News
Chiome Bioscience terminates oncology agreement with Shanghai Henlius Biotech

Japan-based Chiome Bioscience has agreed to terminate the License Agreement for anti-TROP-2 antibody ( LIV-20...

January 23, 2023 | Monday | News
Asieris Pharma appoints Dr Linda Wu as Chief Development Officer

Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising inn...

January 19, 2023 | Thursday | News
Hong Kong to emerge as technology hub for microbiome industry in APAC region

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine), Microbiota I-Center (MagIC), and Hong Kong...

January 18, 2023 | Wednesday | News
Amcor expands healthcare platform in APAC with acquisition of China-based MDK

Amcor, a Switzerland-headquartered firm that develops and produces responsible packaging solutions, has entered into an ...

January 17, 2023 | Tuesday | News
China approves first and only therapy available for patients with EGFR Exon20 Insertion+ NSCLC

Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...

January 12, 2023 | Thursday | News
Hong Kong study identifies more cases of primary brain cancer in high-income countries

Primary brain cancer, though not a common malignancy, has a very poor survival rate compared to other types of cancer; m...

January 11, 2023 | Wednesday | News
Aurisco collaborates with Cytiva to build first Oligo FlexFactory in China

Aurisco, an innovative pharmaceutical company and CDMO (contract development and manufacturing organisation) in China, i...

January 9, 2023 | Monday | News
WuXi Biologics, GSK ink $1.46 B deal for multiple novel bi- & multi-specific T cell engagers

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO), has...

January 5, 2023 | Thursday | News
Former FDA medical device officer joins Pulnovo Medical's scientific advisory board

China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company's Scientific Advisory...

January 16, 2023 | Monday | News
WuXi STA launches first continuous manufacturing line in China for oral solids

WuXi STA, a subsidiary of WuXi AppTec, has announced that its first drug product Continuous Manufacturing (CM) line for ...

January 4, 2023 | Wednesday | News
Biocytogen and Hansoh Pharma announce antibody license agreement in China

Biocytogen Pharmaceuticals and Hansoh Pharmaceutical Group have announced an antibody collaboration, assignment and excl...

January 3, 2023 | Tuesday | News
Mission Bio, Abiosciences to co-develop bioinformatics for clinical research applications in China

US-based Mission Bio and Abiosciences have announced a new partnership to co-develop bioinformatics packages for transla...

December 30, 2022 | Friday | News
GeneQuantum and WuXi XDC to empower innovative bioconjugates development

China-based GeneQuantum Healthcare (GQ) and WuXi XDC, a leading global Contract Research, Development and Manufacturing ...

December 28, 2022 | Wednesday | News
Nasal COVID-19 vaccine stored in NEST Disposable Intranasal Atomisation Device receives EUA in China

On December 2nd, a nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use (EU) by the national auth...

December 27, 2022 | Tuesday | News
China-based startup PVmed raises $14 M in series A funding

Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment startup...

December 23, 2022 | Friday | News
Merck, Kelun-Biotech ink $9.3 B licensing pact for seven cancer candidates in China

Merck, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical in China), a clinical-stage biotech compa...

December 23, 2022 | Friday | News
China nurtures young optometrists by providing clinical training

The Hong Kong Polytechnic University (PolyU) has joined hands with Aier Eye Hospital Group to provide six to eight weeks...

December 22, 2022 | Thursday | News